These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

969 related articles for article (PubMed ID: 28126351)

  • 1. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
    Fossati N; Willemse PM; Van den Broeck T; van den Bergh RCN; Yuan CY; Briers E; Bellmunt J; Bolla M; Cornford P; De Santis M; MacPepple E; Henry AM; Mason MD; Matveev VB; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Lam TB; Mottet N; Joniau S
    Eur Urol; 2017 Jul; 72(1):84-109. PubMed ID: 28126351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pelvic lymph node dissection in prostate cancer.
    Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
    Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
    BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended versus Standard Pelvic Lymph Node Dissection in Radical Prostatectomy on Oncological and Functional Outcomes: A Systematic Review and Meta-Analysis.
    Choo MS; Kim M; Ku JH; Kwak C; Kim HH; Jeong CW
    Ann Surg Oncol; 2017 Jul; 24(7):2047-2054. PubMed ID: 28271172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
    Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
    Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
    Heidenreich A; Ohlmann CH; Polyakov S
    Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
    Narita T; Koie T; Ookubo T; Mitsuzuka K; Narita S; Yamamoto H; Inoue T; Hatakeyama S; Kawamura S; Tochigi T; Habuchi T; Arai Y; Ohyama C
    Med Oncol; 2017 Jan; 34(1):1. PubMed ID: 27889880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes.
    Sagalovich D; Calaway A; Srivastava A; Sooriakumaran P; Tewari AK
    BJU Int; 2013 Jan; 111(1):85-94. PubMed ID: 22823452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis.
    Cacciamani GE; Maas M; Nassiri N; Ortega D; Gill K; Dell'Oglio P; Thalmann GN; Heidenreich A; Eastham JA; Evans CP; Karnes RJ; De Castro Abreu AL; Briganti A; Artibani W; Gill I; Montorsi F
    Eur Urol Oncol; 2021 Apr; 4(2):134-149. PubMed ID: 33745687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
    BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological Outcome After Radical Prostatectomy without Pelvic Lymph Node Dissection for Localized Prostate Cancer: Follow-up Results in a Single Institution.
    Tomisaki I; Ikuta H; Higashijima K; Onishi R; Minato A; Fujimoto N
    Cancer Invest; 2019; 37(10):524-530. PubMed ID: 31597501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature.
    Gakis G; Boorjian SA; Briganti A; Joniau S; Karazanashvili G; Karnes RJ; Mattei A; Shariat SF; Stenzl A; Wirth M; Stief CG
    Eur Urol; 2014 Aug; 66(2):191-9. PubMed ID: 23735200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
    Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature.
    Ploussard G; Briganti A; de la Taille A; Haese A; Heidenreich A; Menon M; Sulser T; Tewari AK; Eastham JA
    Eur Urol; 2014 Jan; 65(1):7-16. PubMed ID: 23582879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role and controversy of pelvic lymph node dissection in prostate cancer treatment: a focused review.
    Dong B; Zhan H; Luan T; Wang J
    World J Surg Oncol; 2024 Feb; 22(1):68. PubMed ID: 38403658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.
    Yaxley JW; Dagher J; Delahunt B; Egevad L; Srigley J; Samaratunga H
    World J Urol; 2018 Jan; 36(1):15-20. PubMed ID: 29116393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review.
    Yuh B; Artibani W; Heidenreich A; Kimm S; Menon M; Novara G; Tewari A; Touijer K; Wilson T; Zorn KC; Eggener SE
    Eur Urol; 2014 May; 65(5):918-27. PubMed ID: 23721959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended pelvic lymph node dissection including internal iliac packet should be performed during robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer.
    Jung JH; Seo JW; Lim MS; Lee JW; Chung BH; Hong SJ; Song JM; Rha KH
    J Laparoendosc Adv Surg Tech A; 2012 Oct; 22(8):785-90. PubMed ID: 22967037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
    Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
    Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Lymph Node Counts and Oncological Outcomes in Lymph Node Positive Prostate Cancer.
    Mandel P; Kriegmair MC; Bogdan K; Boehm K; Budäus L; Graefen M; Huland H; Tilki D
    Eur Urol Focus; 2017 Apr; 3(2-3):248-255. PubMed ID: 28753755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.